A modafinil overdose is usually not life threatening. Most reported cases involve mild to moderate symptoms such as rapid heart rate, agitation, insomnia, dizziness, and anxiety. Severe complications are uncommon but have been documented, including seizures, serious electrolyte disturbances, and, in rare cases, brain swelling. Postmarketing reports have also included fatal overdoses involving modafinil alone or in combination with other drugs.
What Most Overdoses Look Like
The largest published review of single substance modafinil ingestions examined 137 cases reported to US poison centers. Nearly half of patients had no symptoms. Most others experienced mild effects.
The most frequently reported findings were:
- Tachycardia
- Insomnia
- Agitation
- Dizziness
- Increased anxiety
Seventeen percent required medical admission. Additional patients were evaluated in emergency departments and discharged. About one fifth required specific treatment, most commonly benzodiazepines for agitation. Life threatening toxicity was rare.
Elevated heart rate was common, but serious conduction abnormalities were not reported in that series. Blood pressure elevations occurred in a minority of cases. Most patients improved with supportive care.
Dose and Severity
Reported ingested doses ranged from 50 mg to 7,000 mg. The median reported dose in the poison center series was 400 mg.
Higher reported doses were more often associated with moderate effects, but large ingestions did not consistently lead to catastrophic outcomes. A 15 year old who ingested 5,000 mg developed tachycardia, prolonged QTc on ECG, dyskinesia, headache, nausea, and complete insomnia during the first 24 hours. She was monitored in hospital and recovered without lasting complications.
Earlier regulatory summaries noted no confirmed fatal overdoses involving modafinil alone as of 2004. More recent postmarketing data cited in prescribing information state that fatal overdoses involving modafinil alone or in combination with other drugs have been reported. Details of those cases are limited.
A clearly defined lethal dose has not been established.
Rare but Severe Complications
Most overdoses are mild, but serious outcomes have been described.
One case report documented profound hyponatraemia with a sodium level of 116 mmol/L and cerebral oedema after a large modafinil ingestion. The patient required intensive care and hypertonic saline. The authors noted that the exact dose was uncertain and that other substances and medical factors may have contributed. The patient recovered with treatment.
Seizures have also been reported, including in a patient with a pre existing seizure disorder. Agitated delirium and psychotic features have occurred in isolated cases.
These reports show that while severe toxicity is uncommon, it is possible.
What Makes an Overdose More Concerning
Certain factors may increase risk:
- Very high doses
- Underlying seizure disorders
- Psychiatric illness
- Cardiovascular disease
- Severe hepatic impairment
Modafinil has stimulant properties and can produce psychoactive effects. In overdose, agitation and behavioral disturbance may be prominent.
How Overdoses Are Managed
There is no specific antidote. Treatment focuses on monitoring and supportive care.
Patients with significant symptoms may receive:
- Cardiac monitoring
- Sedation for agitation
- Intravenous fluids
- Targeted correction of complications such as electrolyte abnormalities
Most patients recover within one to three days. Modafinil has a half life of approximately 12 to 15 hours, so symptoms such as insomnia or agitation can persist beyond 24 hours.
Children and Accidental Ingestion
In children under six years old, ingestions under 400 mg in the poison center review were generally associated with no or minor effects. Pediatric data remain limited, and modafinil is not approved for use in individuals under 16 years of age.
The Bottom Line
Clinical data show that modafinil overdose is usually mild to moderate and rarely life threatening. Rapid heart rate, agitation, anxiety, and insomnia are the most common effects. Hospital admission is sometimes required, but most patients recover with supportive care.
Severe complications, including seizures, significant electrolyte disturbances, cerebral oedema, and fatal outcomes in postmarketing reports, have been described. These appear to be uncommon rather than typical.
If a modafinil overdose is suspected, prompt medical evaluation is appropriate. Early monitoring and supportive care are generally effective, but high dose ingestion is not without risk.
References
- Greenblatt, K., & Adams, N. (2023). Modafinil. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK531476/
- U.S. Food and Drug Administration. (2015). PROVIGIL® (modafinil) tablets, for oral use, C-IV: Prescribing information. U.S. Department of Health and Human Services. https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020717s037s038lbl.pdf
- Neuman, G., Shehadeh, N., & Pillar, G. (2009). Unsuccessful suicide attempt of a 15 year old adolescent with ingestion of 5000 mg modafinil. Journal of Clinical Sleep Medicine, 5(4), 372–373. https://pubmed.ncbi.nlm.nih.gov/19968017/
- Spiller, H. A., Borys, D., Griffith, J. R., Klein-Schwartz, W., Aleguas, A., Sollee, D., Anderson, D. A., & Sawyer, T. S. (2009). Toxicity from modafinil ingestion. Clinical Toxicology, 47(2), 153–156. https://doi.org/10.1080/15563650802175595
- Kandasamy, R. O., Kaminskaite, V., & May, F. (2020). Hyponatraemia and cerebral oedema due to a modafinil overdose. BMJ Case Reports, 13(7), e234530. https://doi.org/10.1136/bcr-2020-234530